Quadrant Capital Group’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-365
| Closed | -$2.5K | – | 2692 |
|
|
2023
Q3 | $2.5K | Buy |
365
+312
| +589% | +$2.14K | ﹤0.01% | 2330 |
|
|
2023
Q2 | $550 | Sell |
53
-15
| -22% | -$156 | ﹤0.01% | 2558 |
|
|
2023
Q1 | $551 | Buy |
+68
| New | +$551 | ﹤0.01% | 2598 |
|
|
2022
Q3 | – | Sell |
-84
| Closed | -$1K | – | 2619 |
|
|
2022
Q2 | $1K | Hold |
84
| – | – | ﹤0.01% | 2311 |
|
|
2022
Q1 | $1K | Buy |
+84
| New | +$1K | ﹤0.01% | 2230 |
|